Preview

Комплексные проблемы сердечно-сосудистых заболеваний

Расширенный поиск

СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМЫ ЧРЕCКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА ПРИ ПОРАЖЕНИЯХ СТВОЛА ЛЕВОЙ КОРОНАРНОЙ АРТЕРИИ С ИСПОЛЬЗОВАНИЕМ СТЕНТОВ С ЛЕКАРСТВЕННЫМ ПОКРЫТИЕМ

https://doi.org/10.17802/2306-1278-2017-2-23-31

Полный текст:

Аннотация

В данной статье представлен обзор существующих исследований по чрезкожному вмешательству (ЧКВ) на пораженном стволе левой коронарной артерии. Отражено современное состояние данной проблемы, изложены последние рекомендации по эндоваскулярной коронарной реваскуляризации при поражениях ствола левой коронарной артерии.

Об авторах

Р. У. Ибрагимов
Федеральное государственное бюджетное учреждение «Сибирский федеральный биомедицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации
Россия


Д. А. Хелимский
Федеральное государственное бюджетное учреждение «Сибирский федеральный биомедицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации
Россия


О. В. Крестьянинов
Федеральное государственное бюджетное учреждение «Сибирский федеральный биомедицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации
Россия


В. И. Байструков
Федеральное государственное бюджетное учреждение «Сибирский федеральный биомедицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации
Россия


Е. И. Кретов
Федеральное государственное бюджетное учреждение «Сибирский федеральный биомедицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации
Россия


Е. А. Покушалов
Федеральное государственное бюджетное учреждение «Сибирский федеральный биомедицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации
Россия


К. В. Козырь
Федеральное государственное бюджетное учреждение «Сибирский федеральный биомедицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации
Россия


Список литературы

1. Taylor H.A., Deumite N.J., Chaitman B.R. et al., Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry, Circulation 79 (6) (1989) 1171–1179.

2. Cohen V., Gorlin R. Main left coronary artery disease. Clinical experience from 1964–1974. Circulation. 1975; 52: 275–85.

3. Stone P, Goldschlager N. Left main coronary artery disease: review and appraisal. Cardiovasc Med. 1979; 4: 165-177.

4. Farooq V., Serruys P.W., Stone G.W. et al., Left main coronary artery disease, in Percutaneous Interventional Cardiovascular Medicina, in: The PCR-EAPCI Textbook. PCR Publishing; 2012. pp. 329–405.

5. Park S.J., Park D.W. Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines? Circ Cardiovasc Interv. 2009; 2: 59–68.

6. Harskamp R.E., Park D.W. Stenting versus surgery for significant left main disease. Curr Cardiol Rep. 2015; 17: 18.

7. Macaya C., Alfonso F., Iniguez A., et al. Stenting for elastic recoil during coronary angioplasty of the left main coronary artery. American Journal of Cardiology. 1992; 70 (1); 105–107

8. Reig J., Petit M. Main trunk of the left coronary artery: anatomic study of the parameters of clinical interest. Clinical Anatomy. 2004; 17 (1): 6–13.

9. Maehara A., Mintz G.S., Castagna M.T. et al., Intravascular ultrasound assessment of the stenoses location and morphology in the left main coronary artery in relation to anatomic left main length. American Journal of Cardiology. 2001; 88 (1):1–4.

10. Oviedo C., Maehara A., Mintz G.S. et al., Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located? Circulation: Cardiovascular Interventions. 2010; 3 (2):105–112.

11. de la Torre Hernandez M., Baz Alonso J.A., Gomez Hospital J.A. et al., Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC: Cardiovascular Interventions. 2014; 7 (3): 244–254

12. O’Keefe J.H. Jr., Hartzler G.O., Rutherford B.D. et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol. 1989; 64: 144–7.

13. Silvestri M, Barragan P., Sainsous J. et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol. 2000; 35: 1543–50.

14. Tan W.A., Tamai H., Park S.J. et al., for the ULTIMA Investigators. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 2001; 104: 1609–14.

15. Black A., Cortina R., Bossi I. et al. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol. 2001; 37: 832–8.

16. Takagi T., Stankovic G., Finci L. et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002; 106: 698–702.

17. Park S.J., Hong M.K., Lee C.W. et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol. 2001; 38: 1054–60.

18. Осиев А. Г., Мироненко С. П., Кретов Е. И., Бирюков А. В., Ёлкина Д. С., Коледа Н. В., Крестьянинов О. В. Cравнительная клинико-ангиографическая оценка отдаленных результатов коронарного стентирования у больных ишемической болезнью сердца при использовании стентов с различным лекарственным покрытием. Патология кровообращения и кардиохирургия. 2012; 16(2): 45-51. Osiev A. G., Mironenko S. P., Kretov E. I., Biryukov A. V., Elkina D. S., Koleda N. V., Krest'yaninov O. V. Cravnitel'naya kliniko-angiograficheskaya otsenka otdalennykh rezul'tatov koronarnogo stentirovaniya u bol'nykh ishemicheskoy bolezn'yu serdtsa pri ispol'zovanii stentov s razlichnym lekarstvennym pokrytiem. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2012; 16(2): 45-51.

19. Valgimigli M., van Mieghem C.A., Ong A.T. et al. Short- and long-term clinical outcome after drugeluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005; 111: 1383–9.

20. Chieffo A., Stankovic G., Bonizzoni E. et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation. 2005; 111: 791–5.

21. Erglis A., Narbute I., Kumsars I. et al. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. J Am Coll Cardiol. 2007; 50: 491–7.

22. Huang H.W., Brent B.N., Shaw R.E. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology–National Cardiovascular Data Registry (ACC-NCDR). Catheter Cardiovasc Interv. 2006; 68: 867–72.

23. Bangalore S., Kumar S., Fusaro M. et al. Shortand long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012; 125: 2873–91.

24. Palmerini T., Biondi-Zoccai G., Della Riva D. et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012; 379: 1393–402.

25. Levine G.N., Bates E.R., Blankenship J.C. et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011; 124: e574-e651.

26. King S.B., Smith S.C., Hirshfeld J.W. et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2008; 117: 261-295.

27. Windecker S., Kolh P., Alfonso F., Jean-Philippe C., Jochen Crème et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014; 35: 2541–2619.

28. Buszman P.E., Kiesz S.R., Bochenek A. et al., Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. Journal of the American College of Cardiology. 2008; 51 (5): 538–545.

29. Serruys P.W., Morice M.C., Kappetein A.P. et al., Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. New England Journal of Medicine. 2009; 360 (10): 961–972.

30. Mohr F.W., Morice M.C., Kappetein A.P. et al., Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381 (9867): 629–638.

31. Davierwala P., Mohr F.W. Five years after the SYNTAX trial: what have we learnt? European Journal of Cardio- Thoracic Surgery. 2013; 44 (1): 1–3.

32. Morice M.C., Serruys P.W., Kappetein A.P. et al., Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014; 129 (23): 2388–2394.

33. Park S.J., Kim Y.H., Park D.W. et al., Randomized trial of stents versus bypass surgery for left main coronary artery disease. New England Journal of Medicine. 2011; 364 (18): 1718–1727.

34. Ahn M., Roh J.H., Kim Y.H., Park D.W., Yun S.C., Lee P.H. et al., Randomized trial of stents versus bypass surgery for left main coronary artery disease: five-year outcomes of the PRECOMBAT study. Journal of the American College of Cardiology. 2015 May 26; 65(20): 2198-206. doi: 10.1016/j.jacc.2015.03.033

35. Gregg W. Stone, Joseph F. Sabik, Patrick W. Serruys, et al., Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016; 375:2223-2235

36. Seung K.B., Park D.W., Kim Y.H. et al., Stents versus coronary-artery bypass grafting for left main coronary artery disease. New England Journal of Medicine. 2008; 358 (17):1781–1792.

37. Conrotto F., Scacciatella P., D'Ascenzo F. et al., Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). American Journal of Cardiology. 2014; 113 (12): 2007–2012.

38. Naganuma T., Chieffo A., Meliga E. et al., Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC: Cardiovascular Interventions. 2014; 7 (4): 354–361.

39. Alam M., Huang H.D., Shahzad S.A., Kar B., Virani S.S., Rogers P.A. et al. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2): 372-82.

40. Naik H., White A.J., Chakravarty T. et al., A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis/ JACC: Cardiovascular Interventions. 2009; 2 (8):739–747.

41. Valgimigli M., Malagutti P., Aoki J., Garcia-Garcia H.M., Rodriguez Granillo G.A. et al. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. J Am Coll Cardiol. 2006; 47: 507- 514.

42. Lee S.H., Ko Y.G., Jang Y., Kwon H.M., Lee S.H. et al. Sirolimus- versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis. Cardiology. 2005; 104: 181-185.

43. Lee J.Y., Park D.W., Yun S.C., Lee S.W., Kim Y.H. et al. Long-term clinical outcomes of sirolimus-versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN – COMPARE (Revascularization for Unprotected Left main Coronary Artery Stenosis; Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol. 2009; 54: 853-859. 44. Mehilli J., Kastrati A., Byrne R.A., Bruskina O., Iijima R. et al. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2009; 53: 1760-1768.

44. Mehilli J., Richardt G., Valgimigli M., Schulz S., Singh A. et al. Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2013; 62: 2075-2082.

45. Прохорихин А.А, Верин В.В, Осиев А.Г, Ганюков В.И, Протопопов А.В, Демин В.В. и др. Простое слепое проспективное рандомизированное мультицентровое исследование эффективности и безопасности сиролимус-доставляющего коронарного стента «Калипсо» по сравнению с эверолимус-доставляющим стентом Xience Prime: дизайн и обоснование клинического исследования «ПАТРИОТ». Патология кровообращения и кардиохирургия. 2016; 20 (4): 96-101 Prokhorikhin A.A, Verin V.V, Osiev A.G, Ganyukov V.I, Protopopov A.V, Demin V.V. et al. Prostoe slepoe prospektivnoe randomizirovannoe mul'titsentrovoe issledovanie effektivnosti i bezopasnosti sirolimus-dostavlyayushchego koronarnogo stenta «Kalipso» po sravneniyu s everolimus-dostavlyayushchim stentom Xience Prime: dizayn i obosnovanie klinicheskogo issledovaniya «PATRIOT». Patologiya krovoobrashcheniya i kardiokhirurgiya. 2016; 20 (4): 96-101. [I Russ].

46. Valgimigli M., Chieffo A., Lefevre T. et al., Revisiting the incidence and temporal distribution of cardiac and sudden death in patients undergoing elective intervention for unprotected left main coronary artery stenosis in the drug eluting stent era. EuroIntervention. 2007; 2 (4): 435–443.

47. Meliga E., Garcia-Garcia H.M., Valgimigli M. et al., Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. Journal of the American College of Cardiology. 2008; 51 (23): 2212–2219.

48. De Caterina A.R., Cuculi F., Banning A.P. Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents. EuroIntervention. 2013; 8 (11): 1326–1334.

49. Van Mieghem C.A., Cademartiri F., Mollet N.R. et al., Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasound. Circulation. 2006; 114 (7): 645–653.

50. Migliorini A., Valenti R., Marcucci R. et al., High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease. Circulation. 2009; 120 (22): 2214–2221.

51. Березовская Г.А., Ганюков В.И., Карпенко М.А. Рестеноз и тромбоз внутри стента: патогенетические механизмы развития и прогностические маркеры. Российский кардиологический журнал. 2012; 6 (98): 91-95.

52. Berezovskaya G.A., Ganyukov V.I., Karpenko M.A. Restenoz i tromboz vnutri stenta: patogeneticheskie mekhanizmy razvitiya i prognosticheskie markery. Rossiyskiy kardiologicheskiy zhurnal. 2012; 6 (98): 91-95.

53. Feres F., Costa R.A., Abizaid A., Leon M.B., Marin-Neto J.A., Botelho R.V. et al. Three vs.Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial. JAMA 2013; 310(23): 2510–2522.

54. Kim B.K., Hong M.K., Shin D.H., Nam C.M., Kim J.S., Ko Y.G. et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol. 2012; 60(15): 1340–1348.


Для цитирования:


Ибрагимов Р.У., Хелимский Д.А., Крестьянинов О.В., Байструков В.И., Кретов Е.И., Покушалов Е.А., Козырь К.В. СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМЫ ЧРЕCКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА ПРИ ПОРАЖЕНИЯХ СТВОЛА ЛЕВОЙ КОРОНАРНОЙ АРТЕРИИ С ИСПОЛЬЗОВАНИЕМ СТЕНТОВ С ЛЕКАРСТВЕННЫМ ПОКРЫТИЕМ. Комплексные проблемы сердечно-сосудистых заболеваний. 2017;(2):23-31. https://doi.org/10.17802/2306-1278-2017-2-23-31

For citation:


Ibragimov R.U., Khelimskiy D.A., Krestyaninov O.V., Baystrukov V.I., Kretov E.I., Pokushalov E.A., Kozyr K.V. MODERN VIEW ON THE PROBLEMS OF PERCUTANEOUS CORONARY INTERVENTION IN LESIONS OF LEFT MAIN CORONARY ARTERY USING DRUG-ELUTING STENTS. Complex Issues of Cardiovascular Diseases. 2017;(2):23-31. (In Russ.) https://doi.org/10.17802/2306-1278-2017-2-23-31

Просмотров: 147


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)